Stebbins Matthew J, Wilson Hannah K, Canfield Scott G, Qian Tongcheng, Palecek Sean P, Shusta Eric V
Department of Chemical and Biological Engineering, University of Wisconsin-Madison, 1415 Engineering Drive, Madison, WI 53706, United States.
Department of Chemical and Biological Engineering, University of Wisconsin-Madison, 1415 Engineering Drive, Madison, WI 53706, United States.
Methods. 2016 May 15;101:93-102. doi: 10.1016/j.ymeth.2015.10.016. Epub 2015 Oct 27.
The blood-brain barrier (BBB) is a critical component of the central nervous system (CNS) that regulates the flux of material between the blood and the brain. Because of its barrier properties, the BBB creates a bottleneck to CNS drug delivery. Human in vitro BBB models offer a potential tool to screen pharmaceutical libraries for CNS penetration as well as for BBB modulators in development and disease, yet primary and immortalized models respectively lack scalability and robust phenotypes. Recently, in vitro BBB models derived from human pluripotent stem cells (hPSCs) have helped overcome these challenges by providing a scalable and renewable source of human brain microvascular endothelial cells (BMECs). We have demonstrated that hPSC-derived BMECs exhibit robust structural and functional characteristics reminiscent of the in vivo BBB. Here, we provide a detailed description of the methods required to differentiate and functionally characterize hPSC-derived BMECs to facilitate their widespread use in downstream applications.
血脑屏障(BBB)是中枢神经系统(CNS)的一个关键组成部分,它调节血液与大脑之间的物质通量。由于其屏障特性,血脑屏障为中枢神经系统药物递送制造了一个瓶颈。人体体外血脑屏障模型为筛选用于中枢神经系统渗透的药物文库以及开发和疾病中的血脑屏障调节剂提供了一种潜在工具,然而原代模型和永生化模型分别缺乏可扩展性和稳定的表型。最近,源自人类多能干细胞(hPSC)的体外血脑屏障模型通过提供可扩展且可再生的人脑微血管内皮细胞(BMEC)来源,帮助克服了这些挑战。我们已经证明,hPSC来源的BMEC表现出类似于体内血脑屏障的强大结构和功能特征。在这里,我们详细描述了分化hPSC来源的BMEC并对其进行功能表征所需的方法,以促进它们在下游应用中的广泛使用。